Stay updated on Pembrolizumab in ER+/HER2- Breast Cancer Clinical Trial.

Sign up to get notified when there's something new on the Pembrolizumab in ER+/HER2- Breast Cancer Clinical Trial. page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in ER+/HER2- Breast Cancer Clinical Trial. page

  1. Check
    7 days ago
    Change Detected
    Summary
    A service alert has been added regarding planned maintenance on July 26th, indicating that most services will be unavailable for over 12 hours starting at 6 AM EDT.
    Difference
    0.3%
    Check dated 2025-07-09T06:15:42.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The page has been updated to reflect an increase in the number of study locations from 239 to 244, and several new clinical facilities in Kazan, Ryazan, and Moscow have been added. Additionally, the revision number has been updated to v2.16.5.
    Difference
    2%
    Check dated 2025-07-02T02:19:18.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The page has updated the expected modernization date for the ClinicalTrials.gov data ingest to July 2025 and increased the number of study locations from 231 to 239. Additionally, several specific locations in Ukraine have been added.
    Difference
    2%
    Check dated 2025-06-24T22:07:35.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The webpage has updated its clinical trial locations, adding 231 new sites while removing 244 previous sites, indicating a significant restructuring of the study's geographical coverage. Additionally, the last update date has changed to June 2025.
    Difference
    12%
    Check dated 2025-06-17T16:59:45.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.1 to version 2.16.2.
    Difference
    0.0%
    Check dated 2025-06-10T13:53:53.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The web page has been updated to reflect the upcoming modernization of the ClinicalTrials.gov data ingest scheduled for June 2025, along with an invitation for API users to provide input. Additionally, the revision number has been updated from v2.16.0 to v2.16.1.
    Difference
    0.5%
    Check dated 2025-06-03T06:49:43.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in ER+/HER2- Breast Cancer Clinical Trial.

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in ER+/HER2- Breast Cancer Clinical Trial. page.